AI assistant
Sending…
PLUS THERAPEUTICS, INC. — Director's Dealing 2012
Dec 21, 2012
34301_dirs_2012-12-21_b65c907d-cf4e-465d-b0e6-133c73a54f47.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2012-12-19
Reporting Person: Dean Lloyd H (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-12-19 | Common Stock | P | 25000 | $2.85 | Acquired | 40000 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 21000 | Direct |
| Restricted Stock | 10000 | Direct |
Footnotes
F1: Mr. Dean purchased the shares in connection with a public offering of company shares which closed December 19, 2012.
F2: These shares are owned by Lloyd H. Dean,TTE and Suzanne R. Dean, TTE, U/A DTD 8/13/2002, the Dean Family Trust.
More from PLUS THERAPEUTICS, INC.
Capital/Financing Update
2026
Jun 5
Regulatory Filings
2026
Jun 5
Capital/Financing Update
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Apr 21
Board/Management Information
2026
Apr 9
Regulatory Filings
2026
Apr 8
Board/Management Information
2026
Mar 26